Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bipartisan Healthy Americans Act

This article was originally published in The Tan Sheet

Executive Summary

A group of lawmakers led by Sens. Ron Wyden, D-Ore., and Bob Bennett, R-Utah, are set to introduce a bipartisan version of the Healthy Americans Act, S. 334, a comprehensive health care reform bill introduced in January, Wyden's office announced May 2. The new bill will be patterned after S.334, which Wyden co-sponsored and which would provide private health coverage for all people, benefits equal to members of Congress and incentives for insurers and consumers to focus on prevention, wellness and disease management. Spokespersons for Reps. Brian Baird, D-Wash., and Jo Ann Emerson, R-Mo., said they expect to introduce a House version of the bill....

You may also be interested in...

TTS Pharma Wants To Bring First Legal CBD Oil To The UK

TTS Pharma CEO Mark Tucker discusses his ambition to bring a legal CBD oil to the UK market, following the recent submission of a European Union novel food application.

Italy Round-Up: Mylan And Polifarma Strike Deal, OTC Market Stable, Cholesterol-Lowering Probiotic Launch

The latest news from Italy's OTC and supplements markets, including the latest sales figures, business deals, product launches, ad regulation and local association activities.

Sandoz Pledges Price Stability Amid Coronavirus

Sandoz CEO Richard Saynor has pledged that the company will ensure stable pricing for essential coronavirus-related medicines amid concerns over how the outbreak will affect the supply chain.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts